The price of Terns Pharmaceuticals Inc (NASDAQ:TERN) shares last traded on Wall Street fell -2.19% to $5.80.
TERN stock price is now -12.58% away from the 50-day moving average and -17.39% away from the 200-day moving average. The market capitalization of the company currently stands at $501.13M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $82, Oppenheimer recently initiated with Outperform rating for Terns Pharmaceuticals Inc (NASDAQ: TERN). On June 22, 2023, Mizuho recently initiated its ‘Buy’ rating on the stock quoting a target price of $16, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Burroughs Amy L., Chief Executive Officer bought 15,450 shares of the company’s stock on Dec 05 ’24. The stock was bought for $110,468 at an average price of $7.15. Upon completion of the transaction, the Chief Executive Officer now directly owns 19,099 shares in the company, valued at $0.11 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 12 ’24, Director Lu Hongbo bought 476,190 shares of the business’s stock. A total of $4,999,995 was incurred on buying the stock at an average price of $10.50. This leaves the insider owning 476,190 shares of the company worth $2.76 million. A total of 26.68% of the company’s stock is owned by insiders.
During the past 12 months, Terns Pharmaceuticals Inc has had a low of $4.32 and a high of $11.40. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 32.99, and a quick ratio of 32.99. The fifty day moving average price for TERN is $6.669 and a two-hundred day moving average price translates $7.0283 for the stock.
The latest earnings results from Terns Pharmaceuticals Inc (NASDAQ: TERN) was released for 2024-09-30. The company reported revenue of $24.94 million for the quarter, compared to $33.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -24.85 percent.
